Eximius Diagnostics Corp
Los Angeles, CA
- UEI
- CBULAJJVC6A7
- CAGE
- 9HCD6
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1917 Manning Ave APT 4, Los Angeles, CA 90025, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Developing and automating an extracellular vesicle-based test for early detection of hepatocellular carcinoma | National Cancer Institute (NIH) | $1,984,827 |
Quick answers
Is Eximius Diagnostics Corp registered in SAM.gov?
Yes. Eximius Diagnostics Corp's SAM.gov registration is active through February 24, 2027.
What is Eximius Diagnostics Corp's most recent federal award?
Eximius Diagnostics Corp's most recent federal grant award is Developing and automating an extracellular vesicle-based test for early detection of hepatocellular carcinoma (R44CA288163), from National Cancer Institute (NIH), on September 14, 2023.
On GovTribe
See Eximius Diagnostics Corp's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors